227 Dose-response characteristics of bitolterol mesylate in children with asthma

Bierman, C. Warren; Gg, Shapiro; Nathan, R.A.; Jp, Kemp; Mingo, Thomas S.

doi:10.1016/0091-6749(85)90362-8

Cited by 3 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A single treatment with three sprays of bitolterol,'2' and repetitive dosing for 6 weeks with three sprays San Diego, CA, Seattle, WA, Murray, UT, Durham, NC, Madison, WI, Prairie Village, KS, Denver, CO, Hartford, CT, Rensselaer, NY, Colorado Springs, CO, Atlanta, GA. tid,'3' for 3 months with three sprays tid,'4' and for 3 months with two sprays tid'5' have demonstrated bronchodilation for 4 to more than 8 hours. A single treatment, dose-response study in children aged [4][5][6][7][8][9][10][11][12] years old who received one, two, or three sprays of bitolterol by metered-dose inhaler (MDI) revealed that the response was generally dose related, with the maximum effect after three inhalations. The mean duration of bronchodilation was 4 hours, although it persisted in some children for more than 8 hours.…”

Section: Introductionmentioning

confidence: 99%

Comparison of Bitolterol Mesylate and Isoproterenol by Metered-Dose Inhaler for Regular, Long-Term Treatment in Asthmatic Children

Welch¹,

Kemp²,

Bierman³

et al. 1989

Pediatric Asthma, Allergy & Immunology

View full text Add to dashboard Cite

The objective of this study was to compare the efficacy and safety of bitolterol mesylate and isoproterenol hydrochloride, two sprays by metered-dose inhaler three times a day for 3 months in 240 asthmatic children ages 4-12 years. In this double-blind, randomized, parallel, multicenter study, patients received daily bitolterol mesylate or isoproterenol and were evaluated in the office at the beginning of the study and on 3 additional test days at 1-month intervals. They were evaluated by physical exam and ECG, blood and urine analyses, and spirometry for 8 hours after two sprays of the appropriate study aerosol. Theophylline was withheld for 24 hours and the study drug for 12 hours before office study days. All regular asthma medications were continued together with the bitolterol mesylate or isoproterenol between study days. Bronchodilation >15% above baseline occurred in <5 minutes with both treatments. Median durations of action were 3.1-4.4 and 1.2-2.2 hours with bitolterol mesylate and isoproterenol, respectively. Adverse effects were few and did not differ between drugs.

show abstract